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Abstract 
  
Introduction: microRNAs (miRNAs) play important role in the regulation of placental 
development, and abnormal miRNA expression is associated with preeclampsia (PE). 
miRNAs are released from trophoblast cells to maternal blood flow, where they are highly 
stable, being encapsulated inside extracellular vesicles, like exosomes or bound to Argonaute 
proteins. In PE, placental dysfunction leads to aberrant extracellular miRNA secretion. hsa-
miR-210 is a hypoxia-sensitive miRNA found to be upregulated in PE, however, it is 
unknown whether it is the cause or the consequence of the disease. 
Objective: Our aim was to analyze the expression of several miRNAs, including hsa-miR-
210 in placenta, exosome and Ago-bound fractions comparing normal (N) and PE 
pregnancies. We performed in vitro analyses of extracellular hsa-miR-210 secretion of 
trophoblast cell cultures (of villous and extravillous origin) under hypoxic condition.  
Methods: PE and N placenta samples were collected from C-sections, and blood samples 
were drawn from each pregnant woman in the third trimester. Htr-8 and Jar cell lines were 
cultured in exosome-free media and treated with hypoxia-mimetic agents. Exosome and Ago-
bound fractions were isolated by membrane affinity spin column method from plasma and cell 
media. Short RNAs were extracted from exosomes and vesicle-free fractions, and total-RNA 
was isolated from the placenta samples. The RNA purity and concentration were measured by 
spectrophotometry. Expression analysis was carried out by qPCR with specific primers to 
target and reference miRNAs. 
Results: The level of hsa-miR-210 was significantly higher in PE placentas, which could 
cause a minor increase of exosomal and a high elevation of Ago-bound miR-210 in 
circulation. Hypoxia leads to intracellular hsa-miR-210 upregulation in trophoblast cell lines. 
In extravillous cell (HTR8) media, only the level of exosomal hsa-miR-210 was increased but 
no change in Ago-bound hsa-miR-210 level was observed. In contrast, in villous cell (JAR) 
media, the level of exosomal hsa-miR-210 was increased and enhanced release of Ago-bound 
hsa-miR-210 was also observed.  
Conclusion: Based on our data, we postulate that in PE, exosomal hsa-miR-210 are secreted 
actively from the trophoblast, and by intercellular communication, it may have a role in 
disease etiology. In addition, there is a passive release of Ago-bound hsa-miR-210 into the 
circulation, which may represent by-products of cell-death and is thereby a possible 
consequence of the disease.  
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Abstract 
  
Introduction: microRNAs (miRNAs) play important role in the regulation of placental 
development, and abnormal miRNA expression is associated with preeclampsia (PE). 
miRNAs are released from trophoblast cells to maternal blood flow, where they are highly 
stable, being encapsulated inside extracellular vesicles, like exosomes or bound to Argonaute 
proteins. In PE, placental dysfunction leads to aberrant extracellular miRNA secretion. hsa-
miR-210 is a hypoxia-sensitive miRNA found to be upregulated in PE; however, it is 
unknown whether it is the cause or the consequence of the disease. 
Objective: Our aim was to analyze the expression of several miRNAs, including hsa-miR-
210 in placenta, exosome and Ago-bound fractions comparing normal (N) and PE 
pregnancies. We performed in vitro analyses of extracellular hsa-miR-210 secretion of 
trophoblast cell cultures (of villous and extravillous origin) under hypoxic condition.  
Methods: PE and N placenta samples were collected from C-sections, and blood samples 
were drawn from each pregnant woman in the third trimester. HTR-8 and JAR cell lines were 
cultured in exosome-free media and treated with hypoxia-mimetic agents. Exosome and Ago-
bound fractions were isolated by membrane affinity spin column method from plasma and cell 
media. Short RNAs were extracted from exosomes and vesicle-free fractions, and total-RNA 
was isolated from the placenta samples. The RNA purity and concentration were measured by 
spectrophotometry. Expression analysis was carried out by qPCR with specific primers to 
target and reference miRNAs. 
Results: The level of hsa-miR-210 was significantly higher in PE placentas, which could 
cause a minor increase of exosomal and a high elevation of Ago-bound miR-210 in 
circulation. Hypoxia leads to intracellular hsa-miR-210 upregulation in trophoblast cell lines. 
In extravillous cell (HTR-8) media, only the level of exosomal hsa-miR-210 was increased 
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but no change in Ago-bound hsa-miR-210 level was observed. In contrast, in villous cell 
(JAR) media, the level of exosomal hsa-miR-210 was increased and enhanced release of Ago-
bound hsa-miR-210 was also observed.  
Conclusion: Based on our data, we postulate that in PE, exosomal hsa-miR-210 are secreted 
actively from the trophoblast, and by intercellular communication, it may have a role in 
disease etiology. In addition, there is a passive release of Ago-bound hsa-miR-210 into the 
circulation, which may represent by-products of cell-death and is thereby a possible 
consequence of the disease.  
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1. Introduction 
 
1.1. Preeclampsia 
Preeclampsia (PE) is of the leading causes of maternal and fetal morbidity and mortality, 
affecting 3–8% of all pregnancies around the world (Duley, 2009). It is a multisystemic 
pregnancy-specific disorder, characterized by the development of hypertension and 
proteinuria after 20 weeks of gestation. In the absence of proteinuria, the diagnosis may be 
established by the occurrence of other maternal organ failures due to endothelial dysfunction 
(Tranquilli et al., 2014).  
Although the etiology and pathogenesis of PE are debated, the generally accepted theory 
denotes placental malperfusion as the main cause of the disease. In the case of early-onset 
preeclampsia (EOPE, <34 weeks), the placental dysfunction is a consequence of the 
insufficient extravillous trophoblast invasion and spiral arterial remodeling, therefore the 
pathophysiological changes take place well before the clinical manifestations. It has been 
proposed that in late-onset preeclampsia (LOPE, >34 weeks) the placenta exceeds the 
capacity of the uterus and its vasculature to comply with the increasing demands in term 
pregnancy, leading to deficient intervillous perfusion and increased hypoxia (Redman, 2017). 
In both scenarios, maternal blood flow to the placenta is hindered and high perfusion pressure 
constituting shear stress to the villous trophoblast layer. This phenomenon results in 
widespread syncytiotrophoblast (STB) damage and subsequent release of toxic materials 
including cell fragments, antiangiogenic factors, proinflammatory mediators, and extracellular 
vesicles (EVs) that are capable of activating the maternal endothelium.  
 
1.2. Exosomes 
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EVs are lipid bilayer structures that are secreted from all kinds of cells into the 
extracellular space. They comprise proteins, lipids, noncoding RNAs, and other regulatory 
elements. EVs are distinguished by size, function, biogenesis, and morphology into three 
categories: microvesicles, apoptotic bodies, and exosomes. Exosomes are the smallest of EVs 
with a size between 40–120 nm (Kowal et al., 2014). The level and content of placenta-
specific exosomes may provide useful information on placental health. In the course of 
physiologically normal pregnancy, EVs are continuously shed from the STB into the maternal 
circulation. The release of these particles rises with gestation as the placenta grows in size, 
and returns to non-pregnant levels in 48 h after delivery (Salomon et al., 2014a). 
After secretion from cells, exosomes may have a function in intercellular communication. 
Over the last decade, several in vitro studies have been carried out investigating the effect of 
placental vesicles on different target cells (Salomon et al., 2014a, 2014b, 2013a, 2013b; 
Truong et al., 2017). It was demonstrated that they are capable of modulating the activity of 
adjacent cells, which may play a role in the progression and maintenance of physiological 
pregnancy. However, pathological processes can change the number and composition of 
vesicles, which may lead to the development of various pregnancy complications. In PE, the 
excessive shear stress resulting from abnormal placentation leads to morphological damage 
and increased shedding of STB, which may contribute to generalized endothelial dysfunction. 
 
1.3. Placental and cell-free miRNAs 
miRNAs are endogenous, 20–22 nucleotides long, non-coding RNA molecules, which 
play important role in the post-transcriptional regulation of gene expression by either 
repressing protein translation or inducing mRNA degradation. They are involved in 
fundamental biological process, such as cell proliferation, differentiation, apoptosis and have 
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been linked to the pathogenesis of several human diseases (Gebert and MacRae, 2018; Li and 
Kowdley, 2012).  
Several hundred miRNAs are expressed by different layers of the human placenta; 
however, their function in pregnancy is not fully elucidated. miRNAs take part in the 
regulation of placental development, and abnormal miRNA expression is associated with 
pregnancy complications including PE (Fu et al., 2013). miRNAs are released from 
trophoblast cells to maternal blood flow, where they are highly stable, being encapsulated 
inside extracellular vesicles (like exosomes) or bound to stabilizing proteins (mainly 
Argonaute proteins) (Ouyang et al., 2014). Cells seem to selectively release certain non-
coding RNAs, thereby affecting the function of surrounding and distant target cells. Exosomal 
miRNAs can be internalized by recipient cells, where they mediate functional effects by 
altering host gene expression (Valadi et al., 2007). The miRNA expression patterns of the 
source cell and released exosomes are usually different, which supports the idea of active 
exosomal miRNA sorting. However, exosomal miRNAs constitute only a minor fraction of 
the whole plasma miRNA population, the majority of which are Ago-bound miRNAs 
(Turchinovich et al., 2011). Non-vesicular miRNAs are believed to be non-specific by-
products of general physiological processes and cell death, however, their significance is not 
known (Schwarzenbach et al., 2014).  It has been proposed that vesicle- versus Ago complex-
associated miRNAs originate from different cell types and reflect cell type-specific miRNA 
expression and/or release mechanisms (Arroyo et al., 2011). Ago-specific miRNA profile in 
blood cells and in the whole plasma differs significantly indicating that most circulating non-
vesicular miRNAs are likely to be derived from non-blood cells (Turchinovich and 
Burwinkel, 2012). 
 
1.4. hsa-miR-210 hypoxamiR 
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In PE, deficient trophoblast invasion and spiral arterial remodeling lead to prolonged 
placental hypoxia. hsa-miR-210 is a hypoxia-induced miRNA and considered as one of the 
hallmarks of hypoxic responses in several cell types, including trophoblast and endothelial 
cells (Chan and Loscalzo, 2010). HIF-1α is directly recruited to the hypoxia-responsive 
element (HRE) in the hsa-miR-210 promoter region and triggers miRNA transcription (Huang 
et al., 2010, 2009). 
The direct effect of the elevated hsa-miR-210 level on pregnancy is currently unknown. In 
our previous study, we have created a miRNA regulated interaction network by the 
integration of available miRNA and gene expression profiles in preeclampsia, and hsa-miR-
210 was the highest degree node in the network (Biró et al., 2017a). It has been associated 
with preeclampsia before (Sheikh et al., 2016), however, it is questionable whether it is the 
cause or the consequence of the disease. The mode of miRNA secretion (exosomal or Ago-
bound) and the significance of the different forms are not clarified either. In this study, we 
hypothesized that extracellular hsa-miR-210 profile differs in PE and normal pregnancy 
which could be the result of abnormal placental miRNA expression and secretion in case of 
PE.  
Our aim was to analyze the expression of hsa-miR-210 in placenta, exosome and Ago-
bound fractions comparing PE and N pregnancies. Apart from hsa-miR-210, the expression of 
hsa-miR-16 and hsa-miR-517c was also measured and used for comparison. hsa-miR-16 is 
one of the most abundant miRNAs in blood, found to be expressed mainly by red blood cells 
(Pritchard et al., 2012). hsa-miR-517c is part of the primate-specific C19MC miRNA cluster, 
which is abundantly expressed in the placenta (Noguer-Dance et al., 2010). We performed an 
in vitro analysis of extracellular miRNA secretion of different trophoblast cell cultures under 
normoxic and hypoxic conditions.  
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2. Materials and methods 
 
2.1. Study participants 
Study participants had been recruited during routine prenatal care or following 
hospital admission during the third trimester of pregnancy at 1st Department of Obstetrics and 
Gynecology, Semmelweis University, Budapest, Hungary. In this study 16 plasma and 20 
placenta samples were included, 8 vs. 8 and 13 vs. 7 preeclamptic (PE) and normal (N) cases 
respectively. Inclusion criteria for the PE group were blood pressure greater than 140/90 
mmHg with proteinuria>300 mg/24 h or at least 1 g/L (++) on dipstick testing. Pregnancies 
with ongoing labour, multiple gestations, and congenital malformations were not included. In 
the normotensive group, exclusion criteria also included the history of pregnancy-related or 
other forms of hypertension, spontaneous abortion, preterm birth, and intrauterine growth 
restriction. Placenta samples were collected from C-sections and blood samples were drawn 
from each pregnant woman in the third trimester.  
The study protocol was approved by the Scientific and Research Ethics Committee of 
the Medical Research Council (ETT TUKEB) [No: 24387-2/2016] and written informed 
consent was obtained from each patient. The research was conducted in accordance with the 
Declaration of Helsinki. 
 
2.2. Sample collection and handling 
Venous blood samples were collected into 4 mL EDTA tubes and kept at 4 °C until 
processing. Plasma was separated within few hours by two-step centrifugation (1. 2500g, 10 
min, 4 °C, 2. 12500g, 10 min, 4 °C) and stored in 1.5 ml Eppendorf tubes at −80 °C. 
Placenta samples were collected according to the protocol described by Pasupathy et 
al. (Pasupathy et al., 2008). Four areas suitable for sampling were located on the maternal 
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surface; damaged areas not suitable for further examination (calcification, hematoma, etc.) 
were excluded. 1-2 mm from the basal membrane was removed and a pea size tissue sample 
was taken from the placental cotyledons. The samples were washed twice in 1x PBS solution 
at 4 °C and placed in RNAlater (Thermo Fisher Scientific) stabilizing solution to avoid RNA 
degradation.  
 
2.3. Cell culture and treatment 
We used JAR and HTR-8 placenta-derived cell lines. The former is a choriocarcinoma 
cell line and has the characteristics of villous trophoblasts (VT), while the latter one is an 
immortalized extravillous trophoblast (EVT) cell line.  
JAR and HTR-8 cell lines were maintained under standard conditions at 37°C and 5% 
CO2 in RPMI-1640 (Gibco) or DMEM (Gibco) medium respectively, supplemented with 10% 
FBS (Gibco) and 1% penicillin-streptomycin. 4 x 10
5
 cells were seeded per well on six-well 
plates in media containing 10% exosome-depleted FBS. Cells were treated after 24 hours with 
hypoxia-mimetic agent (100 M DFO or 50 M DFX), or DMSO as control and maintained 
under standard conditions for another 24 hours. DFO and DFX are well-known iron chelators 
used for modeling hypoxic conditions in cell cultures. 
 
2.4. Total-RNA and miRNA isolation  
Exosomes were isolated from plasma and cell media using the ExoRNEasy kit, which 
applies membrane affinity spin column method (Qiagen). As compared to ultracentrifugation, 
this method is faster and yields a cleaner preparation of exosomes (Enderle et al., 2015). 
Exosomes were bound to the column membrane and protein complexes were partitioned to 
the flow-through. Short RNAs were extracted from exosomes and vesicle-free fractions.  
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Total-RNA was isolated from the placenta samples and cultured trophoblast cell lines 
using the TRIzol ™ lysis reagent (Thermo Fisher Scientific) according to the manufacturer’s 
protocol. The RNA purity and concentration were measured by Nanodrop spectrophotometer 
(Thermo Fisher Scientific).  
 
2.5. Expression analysis 
The expression analysis was performed using the miRCURY LNA™ Universal RT 
miRNA PCR Assay (Qiagen) according to the manufacturer’s instructions. Briefly, RNA 
samples (5 ng/µl) were reverse-transcribed using the miRCURY LNA™ RT Kit. UniSp6 
RNA spike-in template was added to each reaction for cDNA synthesis control. cDNAs of 
placental and cell culture RNAs were 1:80 diluted, whilst templates from exosomal and Ago-
bound miR fractions were 1:10  diluted before subsequent amplification. RT-PCR was carried 
out using miRCURY SYBR® Green master mix with specific LNA™ PCR primer sets, run 
on a StepOnePlus™ platform (Thermo Fisher Scientific) using the manufacturer’s 
instructions. The relative expression of the investigated miRNAs was calculated based on the 
CT method and was normalized to hsa-miR-103a internal control miRNA. The miRBase 
identifiers and seed sequences of investigated and reference miRNAs are listed in Table 1. 
Melting curve analysis was carried out following each PCR run for evaluating the specificity 
of the assays. 
 
2.6. Statistics 
We used the STATISTICA software package (Statistica, Tulsa, Oklahoma, USA) for 
statistical analysis.  Shapiro-Wilk W test was applied to assess the normality of the dependent 
variables. None of the miRNA expression values of placenta and plasma samples followed a 
normal distribution, thus comparisons between groups were performed using the 
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nonparametric Mann-Whitney U test and exact probabilities were calculated. The data were 
represented on box plots, where miRNA levels were shown as median with interquartile 
ranges. The miRNA expression values of cell culture were logarithmized and one-sided t-test 
was applied. The data were represented on barplots, where the untransformed miRNA levels 
were shown as mean with standard error.  A p value of <0.05 considered as a statistically 
significant finding. 
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3. Results 
 
3.1. Patient characteristics 
In the first part of the study, we analyzed the expression of hsa-miR-210 in placenta, 
exosome and Ago-bound plasma fractions comparing PE and N pregnancies. 16 plasma and 
20 placenta samples were included, 8 vs. 8 and 13 vs. 7 PE and N cases respectively. The 
patient characteristics of the collected plasma and placenta samples are summarized in Table 
2 and 3.  
 
3.2. Placental and extracellular hsa-miR-210 expression 
The level of placental hsa-miR-210 was significantly upregulated in affected samples 
comparing to the control group (Figure 1A), which could be related to a minor increase of 
circulating exosomal (Figure 1B) and significantly elevated Ago-bound hsa-miR-210 (Figure 
1C). We found that hsa-miR-210 was overrepresented in the Ago-bound fraction compared to 
exosomal fraction in the PE but not in the N group.  
The level of placental hsa-miR-517c was significantly upregulated in affected samples 
comparing to the control group (Figure 2A), but there was no significant difference in the 
level of extracellular hsa-miR-517c between groups (Figure 2B,C). Neither the level of 
placental hsa-miR-16 (Figure 3A) nor extracellular hsa-miR-16 was altered due to PE (Figure 
3B,C). 
 
3.3. In vitro hsa-miR-210 secretion from trophoblast cell-lines 
In the second part of the study, we performed an in vitro analysis of extracellular hsa-
miR-210 secretion of different trophoblast cell cultures under normoxic and hypoxic 
conditions.  
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3.3.1. Effect of hypoxia on JAR cells and secreted cell-free miRNAs 
The treatment of villous trophoblast cells with hypoxia-mimetic agent selectively 
upregulated hsa-miR-210 as compared to the other examined miRNA species (Figure 4A). In 
the cell media, the level of exosomal hsa-miR-210 was significantly increased and enhanced 
release of Ago-bound miRNAs was also observed (Figure 4B,C). There was no significant 
difference in the case of hsa-miR-16, and hsa-miR-517c. 
 
3.3.2. Effect of hypoxia on HTR-8 cells and secreted cell-free miRNAs 
The treatment of the extravillous trophoblast cells with hypoxia-mimetic agent 
strongly upregulated hsa-miR-210 (Figure 5A), and this phenomenon was even more 
pronounced in secreted exosomal samples: only the level of exosomal hsa-miR-210 was 
increased (Figure 5B) and a no significant change on Ago-bound hsa-miR-210 level was 
observed (Figure 5C). There was no significant difference in the case of hsa-miR-16 and hsa-
miR-517c is not expressed in this cell line. 
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4. Discussion 
Exosomes have been shown to be capable of modulating the activity of adjacent cells, 
which may play a role in the development and maintenance of physiological pregnancy. Over 
the last decade, several in vitro studies have been carried out investigating the effect of 
placental vesicles on different target cells. Salamon et al. demonstrated that EVT exosomal 
signaling may contribute to spiral artery remodeling by enhancing the migration of vascular 
smooth muscle cells out of the vessel walls. They propose that during a normal placentation, 
EVT-derived exosomes that contain specific regulatory molecules (e.g. miRNAs) promote 
loss of vascular cells facilitating remodeling of the spiral uterine arteries (Salomon et al., 
2014b). The same group investigated the bioactivity of circulating placental exosomes and 
they found that treating HUVEC (Human Umbilical Vein Endothelial Cell) culture with these 
vesicles increases endothelial cell migration. Importantly, the bioactivity of exosomes was the 
greatest in the first trimester and decreased with the progression of pregnancy. Their results 
indicate that in a healthy pregnancy, trophoblast-derived exosomes may facilitate the maternal 
vascular adaptation to pregnancy (Salomon et al., 2013a). They have also shown that in 
response to changes in oxygen tension, cytotrophoblast cells modify the bioactivity and 
protein-content of the secreted exosomes, which were able to alter EVT phenotype. Exosomal 
induction of EVT migration may represent an adaptive response to placental hypoxia in the 
first trimester (Salomon et al., 2013b). 
Pathological processes may change the number and composition of vesicles, which may 
lead to the development of various pregnancy disorders. In PE, the presence of extensive 
hypoxia and accumulated proinflammatory cytokines (e.g. TNF-α) may inhibit the beneficial 
effect of exosomes on vascular cell migration leading to inadequate arterial remodeling. 
Truong et al. showed that the level of exosomes secreted by EVTs is significantly higher at 
1% O2 than 8% O2. Exosomes isolated from EVT cells cultured in normoxia contained 
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miRNAs linked with cell migration, while exosomes isolated from EVT cultured in hypoxia 
had miRNAs associated with inflammatory response and regulation of cytokine production. 
They conclude that oxygen tension modifies the effect of EVT-derived exosomes on 
endothelial cells, thereby hypoxic condition inhibits EVT migration out of the artery and 
increases the concentration of TNFα at the site of remodeling. Abnormal EVT function may 
result in compromised placental perfusion and prolonged hypoxia leading to pregnancy 
complications (Truong et al., 2017). 
The placental dysfunction causes the enhanced shedding of trophoblast-derived EVs into 
the maternal circulation, which may provoke drastic biological changes systemically. There is 
a growing evidence for STB EV’s function in the immunological adaptations to pregnancy. 
Their role in the activation of the innate immune system has been indicated by that monocytes 
can bind and internalize STB EVs. As a result, monocytes start producing various cytokines, 
such as TNF-α, and IL-1β. Based on data from in vitro studies, it can be suggested that STB 
EVs may support the exaggerated inflammatory state observed in preeclamptic pregnancies 
(Göhner et al., 2017).  
We investigated placental, exosomal and Ago-bound hsa-miR-210 expression profile in 
PE vs. N groups. The level of hsa-miR-210 was significantly higher in PE placentas, which 
could be associated with a minor increase of circulating exosomal, and highly elevated Ago-
bound hsa-miR-210. In our former study, we found that the concentration of total-miRNA and 
exosomal hsa-miR-210 was significantly higher in the circulation of women affected by PE 
(Biró et al., 2017b). The difference in the exosomal expression levels could be due to the 
different sample numbers and exosome isolation techniques applied it the two studies. 
It has been shown that hsa-miR-210 is expressed by several parts of the cardiovascular 
system (Chan et al., 2012), thus it may be also a potential surface for releasing hsa-miR-210 
into the maternal circulation. Similarly to the placenta, cancer cells actively release exosomes 
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carrying specific regulatory and signaling molecules to communicate with various cells in the 
tumor microenvironment. Jung et al visualized exosome-mediated transfer of hsa-miR-210 
from hypoxic breast cancer cells to neighboring cells using a specific reporter system. They 
found that exosomal hsa-miR-210 was transferred to cells in the tumor milieu, where it 
regulated the expression of vascular remodeling related genes to promote angiogenesis. These 
results demonstrated well that in cancer, particular cellular miRNAs are secreted and 
transferred to proximal cells via exosomes and through this mechanism, they are able to 
influence tumor progression (Jung et al., 2017). Hale et al proposed that the Argonaute 2-
dependent control of released hsa-miR-210 is also possible and it synchronizes the hypoxic 
response in different cell-types, preventing redundant activity of delivered hsa-miR-210 in 
normoxia while potentiating the adaptation of recipient tissues to hypoxic stress. They 
demonstrated that released hsa-miR-210 can be transferred to recipient cells, where it 
downregulates the mitochondria-associated iron-sulfur scaffold homologue (ISCU), thereby 
suppressing mitochondrial metabolism (Hale et al., 2014). 
We performed an in vitro analysis of extracellular hsa-miR-210 secretion of different 
trophoblast cell cultures under normoxic and hypoxic conditions. Hypoxia-induction had a 
different effect on the villous and extravillous trophoblast cell lines. The intracellular hsa-
miR-210 was upregulated in both cases, however, in extravillous cell media, only the level of 
exosomal hsa-miR-210 was increased and a no change on Ago-bound hsa-miR-210 level was 
observed. Therefore, in this case, hypoxia resulted in the specific exosomal sorting of hsa-
miR-210 – as this cell type has a role in trophoblast invasion, this phenomenon may have a 
role in placental dysfunction. In villous cell media, the level of exosomal hsa-miR-210 was 
increased and enhanced release of Ago-bound hsa-miR-210 was also observed. The 
expression profile was quite similar to that of the placenta and plasma samples – which can be 
explained by the fact in placenta this cell type is in contact with maternal circulation. Based 
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on these data, we suggest the use of JAR trophoblast cell-line for modeling mature placenta 
physiology and function, while the HTR-8 trophoblast cell-line is more appropriate for the 
investigation of placenta development and pathogenesis of associated diseases. 
The hypoxia-induced hsa-miR-210 regulates numerous biological processes both in 
physiological and pathogenic circumstances. It is overexpressed in most solid tumors, and its 
levels correlate with a negative clinical outcome. Several genes have been experimentally 
validated and even more were predicted as targets of hsa-miR-210. These genes play 
important roles in various cellular processes such as proliferation, apoptosis, differentiation, 
angiogenesis, and metabolism. Elevated levels of hsa-miR-210 may lead to placental 
mitochondria dysfunction and oxidative stress by the repression of ISCU (Lee et al., 2011). 
Supporting its pathogenic role, the targeted mRNA was significantly reduced with 
concomitant hsa-miR-210 overexpression in preeclamptic placenta samples 
(Muralimanoharan et al., 2012).  Ishibashi et al. showed that hsa-miR-210 regulates 17-beta-
hydroxysteroid dehydrogenase (HSD17B1), a steroidogenic enzyme expressed predominantly 
in the placenta. The plasma HSD17B1 protein levels, as well as the placental expression, was 
decreased in preeclamptic pregnant women (Ishibashi et al., 2012). Ephrin-A3 (EFNA3) and 
Homeobox-A9 (HOXA9) are also validated targets of hsa-miR-210, EFNA3 is a key regulator 
of vascularization and cell migration, while HOXA9 plays an important role in angiogenesis 
(Fasanaro et al., 2008; Zhang et al., 2012). Anton et al. demonstrated that overexpressing hsa-
miR-210 reduces trophoblast invasion and vice versa, hsa-miR-210 inhibition promotes 
invasion. Moreover, they conclude that it may help to identify at-risk women for monitoring 
and treatment since elevated first-trimester serum hsa-miR-210 expression was predictive of 
the disease (Anton et al., 2013). All of the referred mechanisms regulated by hsa-miR-210 are 
associated with the development of PE, including disturbed trophoblast invasion, and 
oxidative stress.   
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5. Conclusions 
We investigated placental, exosomal and Ago-bound hsa-miR-210 expression profile 
in PE vs N groups. The level of hsa-miR-210 was significantly higher in PE placentas, which 
could be related to a minor increase of circulating exosomal and highly elevated Ago-bound 
hsa-miR-210. The hypoxia-induction had a different effect on the villous and extravillous 
trophoblast cell lines: intracellular hsa-miR-210 was upregulated in both cases, however, in 
extravillous cell media, only the level of exosomal hsa-miR-210 was increased and a no 
change on Ago-bound hsa-miR-210 level was observed. Therefore, in this case, hypoxia 
resulted in the specific exosomal sorting of hsa-miR-210 – as this cell type has a role in 
trophoblast invasion, this phenomenon may have a role in placental dysfunction. In villous 
cell media, the level of exosomal hsa-miR-210 was increased and enhanced release of Ago-
bound hsa-miR-210 was also observed. The expression profile was quite similar to that of the 
placenta and plasma samples which can be explained by the fact that in placenta this cell type 
is in contact with maternal circulation.  
Based on our results, we postulate that in PE, exosomal hsa-miR-210 is secreted 
actively from the trophoblast, which may have a role in intercellular communication and play 
a role in disease etiology. Moreover, there is also a passive release of Ago-bound hsa-miR-
210, which could be the by-product of cell-death and so it is a possible consequence of the 
disease. 
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Figure Legends 
 
Figure 1. Placental (A), exosomal (B), and Ago-bound (C) hsa-miR-210 expression in N vs. 
PE group.  
miRNA levels are shown as median with interquartile ranges, *: p < 0.05, **: p < 0.01. 
 
Figure 2. Placental (A), exosomal (B), and Ago-bound (C) hsa-miR-517c expression in N vs. 
PE group.  
miRNA levels are shown as median with interquartile ranges, *: p < 0.05. 
 
Figure 3. Placental (A), exosomal (B), and Ago-bound (C) hsa-miR-16 expression in N vs. 
PE group. 
miRNA levels are shown as median with interquartile ranges. 
 
Figure 4. Intracellular (A), exosomal (B), Ago-bound (C) miRNA expression in JAR cells in 
hypoxia. 
Untransformed miRNA levels are shown as mean with standard error, *: p < 0.05. 
 
Figure 5. Intracellular (A), exosomal (B), Ago-bound (C) miRNA expression in HTR8 cells 
in hypoxia.  
Untransformed miRNA levels are shown as mean with standard error, *: p < 0.05.  
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Table Legends 
 
Table 1. Investigated and reference miRNAs. 
 
Table 2. Patient characteristics of plasma samples.  
Values are given as mean with standard deviation. N: Normal group, PE: Preeclamptic group. 
 
Table 3. Patient characteristics of placenta samples. 
Values are given as mean with standard deviation. N: Normal group, PE: Preeclamptic group. 
1 
 
miRNA name mirBase identifier seed sequence 
hsa-miR-210-3p MIMAT0000267 5’-CUGUGCGUGUGACAGCGGCUGA-3’ 
hsa-miR-16-5p MIMAT0000069 5'-UAGCAGCACGUAAAUAUUGGCG-3’ 
hsa-miR-517c-3p MIMAT0002866 5'-AUCGUGCAUCCUUUUAGAGUGU-’3 
hsa-miR-103a-3p MIMAT0000101 5'-AGCAGCAUUGUACAGGGCUAUGA-’3 
 
Table 1
1 
 
 
 
 
 
 
 
 
 
 
  N PE p-value 
n 8 8   
gestational age at sampling (weeks) 36,13 ± 3,00 31,00 ± 5,07 <0,05 
gestational age at birth (weeks) 37,38 ± 1,85 31,13 ± 5,17 <0,05 
birth weight (grams) 3313,75 ± 569,69 1798,29 ± 1254,50 <0,05 
maternal  age (years) 31,25 ± 5,80 33,43 ± 6,48 >0,05 
Table 2
1 
 
  N PE p-value 
n 7 13   
gestational age at birth (weeks) 38,14 ± 0,69 30,39 ± 4,59 <0,05 
birth weight (grams) 3446,67 ± 525,23 1529,00 ± 990,75 <0,05 
maternal age (years)  30,29 ± 6,16 33,67 ± 5,43 >0,05 
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